Literature DB >> 27106906

Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.

Gilles Allali1,2, Magali Laidet3, Stéphane Armand4, Charlotte Elsworth-Edelsten3,4, Frédéric Assal3, Patrice H Lalive3,5.   

Abstract

Fear of falling (FOF) and gait disorders represent both prevalent symptoms in patients with multiple sclerosis (MS); however, the association between FOF and higher level of gait control (HLGC) has not been studied in MS. This study aims to assess the association between FOF and HLGC in patients with MS. HLGC was assessed by stride time variability (STV) during single and dual-tasks (forward counting, backward counting, categorical verbal fluency and literal verbal fluency) and FOF was quantified by the falls efficacy scale-international (FES-I). Seventy-one patients (age: 39.27 ± 9.77 years; 63 % female) were included in this cross-sectional study (Expanded Disability Status Scale (median): 2.00) with a low prevalence of FOF (FES-I: 21.52 ± 8.37). The mean gait speed was 1.19 ± 0.23 m/s with a STV of 2.35 ± 1.68 % during single walking task. STV during single task and the dual tasks of forward counting and backward counting were associated with the FES-I in the univariable linear regression models (p ≤ 0.001), but only STV while backward counting (β: 0.42, [0.18;0.66]) was associated with FOF in the multivariable model (adjusted for age, gender, previous fall, Expanded Disability Status Scale and gait speed). These findings indicate that FOF is associated with STV while backward counting, a marker of HLGC in relationship with working memory in a MS population including a majority of low disabled patients.

Entities:  

Keywords:  Dual task; Falls; Fear of falling; Gait disorders; Multiple sclerosis

Mesh:

Year:  2016        PMID: 27106906     DOI: 10.1007/s00702-016-1551-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  26 in total

1.  Quantifying gait abnormalities in persons with multiple sclerosis with minimal disability.

Authors:  Jacob J Sosnoff; Brian M Sandroff; Robert W Motl
Journal:  Gait Posture       Date:  2012-03-17       Impact factor: 2.840

2.  Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability.

Authors:  Gilles Allali; Magali Laidet; Francois R Herrmann; Stéphane Armand; Charlotte Elsworth-Edelsten; Frédéric Assal; Patrice H Lalive
Journal:  J Neural Transm (Vienna)       Date:  2016-02-04       Impact factor: 3.575

3.  Development and initial validation of the Falls Efficacy Scale-International (FES-I).

Authors:  Lucy Yardley; Nina Beyer; Klaus Hauer; Gertrudis Kempen; Chantal Piot-Ziegler; Chris Todd
Journal:  Age Ageing       Date:  2005-11       Impact factor: 10.668

4.  Regional Gray Matter Volumes Are Related to Concern About Falling in Older People: A Voxel-Based Morphometric Study.

Authors:  Carola Tuerk; Haobo Zhang; Perminder Sachdev; Stephen R Lord; Henry Brodaty; Wei Wen; Kim Delbaere
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-02-01       Impact factor: 6.053

5.  Motor cortex and gait in mild cognitive impairment: a magnetic resonance spectroscopy and volumetric imaging study.

Authors:  Cédric Annweiler; Olivier Beauchet; Robert Bartha; Jennie L Wells; Michael J Borrie; Vladimir Hachinski; Manuel Montero-Odasso
Journal:  Brain       Date:  2013-03       Impact factor: 13.501

6.  Adapted timed up and go: a rapid clinical test to assess gait and cognition in multiple sclerosis.

Authors:  G Allali; M Laidet; F Assal; O Beauchet; M Chofflon; S Armand; P H Lalive
Journal:  Eur Neurol       Date:  2012-01-10       Impact factor: 1.710

7.  Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.

Authors:  R A Sperling; C R Guttmann; M J Hohol; S K Warfield; M Jakab; M Parente; E L Diamond; K R Daffner; M J Olek; E J Orav; R Kikinis; F A Jolesz; H L Weiner
Journal:  Arch Neurol       Date:  2001-01

8.  Influence of executive function on locomotor function: divided attention increases gait variability in Alzheimer's disease.

Authors:  Pamela L Sheridan; Judi Solomont; Neil Kowall; Jeffrey M Hausdorff
Journal:  J Am Geriatr Soc       Date:  2003-11       Impact factor: 5.562

9.  Dual-task decrements in gait: contributing factors among healthy older adults.

Authors:  Jeffrey M Hausdorff; Avraham Schweiger; Talia Herman; Galit Yogev-Seligmann; Nir Giladi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-12       Impact factor: 6.053

Review 10.  Fear of falling: measurement strategy, prevalence, risk factors and consequences among older persons.

Authors:  Alice C Scheffer; Marieke J Schuurmans; Nynke van Dijk; Truus van der Hooft; Sophia E de Rooij
Journal:  Age Ageing       Date:  2008-01       Impact factor: 10.668

View more
  5 in total

1.  Gait and cognitive impairments in multiple sclerosis: the specific contribution of falls and fear of falling.

Authors:  Alon Kalron; Gilles Allali
Journal:  J Neural Transm (Vienna)       Date:  2017-07-22       Impact factor: 3.575

Review 2.  Management of Gait Changes and Fall Risk in MCI and Dementia.

Authors:  Gilles Allali; Joe Verghese
Journal:  Curr Treat Options Neurol       Date:  2017-09       Impact factor: 3.598

3.  Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors.

Authors:  Sapir Dreyer-Alster; Shay Menascu; Roy Aloni; Uri Givon; Mark Dolev; Anat Achiron; Alon Kalron
Journal:  Ther Adv Neurol Disord       Date:  2022-07-04       Impact factor: 6.430

Review 4.  Review-Emerging Portable Technologies for Gait Analysis in Neurological Disorders.

Authors:  Christina Salchow-Hömmen; Matej Skrobot; Magdalena C E Jochner; Thomas Schauer; Andrea A Kühn; Nikolaus Wenger
Journal:  Front Hum Neurosci       Date:  2022-02-03       Impact factor: 3.169

5.  Continuous positive airway pressure improves gait control in severe obstructive sleep apnoea: A prospective study.

Authors:  Sébastien Baillieul; Bernard Wuyam; Jean-Louis Pépin; Mathieu Marillier; Renaud Tamisier; Dominic Pérennou; Samuel Verges
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.